In a preclinical glioblastoma study, Hu et al reported a strong correlation between D* and CD31+ expression, as well as D and TUNEL staining following cyclophosphamide therapy, which may suggest their value as imaging biomarkers [37]. The gene discussed is PECAM1; the disease is glioblastoma.